These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 27023060

  • 1. Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease.
    Maul LV, Weichenthal M, Kähler KC, Hauschild A.
    J Immunother; 2016 May; 39(4):188-90. PubMed ID: 27023060
    [Abstract] [Full Text] [Related]

  • 2. A rapid response to pembrolizumab in a patient with metastatic melanoma.
    Bayo Calero J, Aviñó Tarazona V.
    Immunotherapy; 2017 Mar; 9(3):225-228. PubMed ID: 28231724
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pembrolizumab versus Ipilimumab in Advanced Melanoma.
    Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank CU, Hamid O, Mateus C, Shapira-Frommer R, Kosh M, Zhou H, Ibrahim N, Ebbinghaus S, Ribas A, KEYNOTE-006 investigators.
    N Engl J Med; 2015 Jun 25; 372(26):2521-32. PubMed ID: 25891173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immune checkpoint antibodies increase survival in patients with metastatic melanoma].
    Fløe LE, Svane IM, Bastholt L, Schmidt H.
    Ugeskr Laeger; 2016 Aug 15; 178(33):. PubMed ID: 27550784
    [Abstract] [Full Text] [Related]

  • 7. Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.
    Kwatra V, Karanth NV, Priyadarshana K, Charakidis M.
    J Med Case Rep; 2017 Mar 19; 11(1):73. PubMed ID: 28315636
    [Abstract] [Full Text] [Related]

  • 8. Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.
    Faghfuri E, Faramarzi MA, Nikfar S, Abdollahi M.
    Expert Rev Anticancer Ther; 2015 Mar 19; 15(9):981-93. PubMed ID: 26313415
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety of pembrolizumab for the treatment of melanoma.
    Martin-Liberal J, Kordbacheh T, Larkin J.
    Expert Opin Drug Saf; 2015 Jun 19; 14(6):957-64. PubMed ID: 25927979
    [Abstract] [Full Text] [Related]

  • 11. Durable Response of Metastatic Squamous Cell Carcinoma of the Skin to Ipilimumab Immunotherapy.
    Day F, Kumar M, Fenton L, Gedye C.
    J Immunother; 2017 Jan 19; 40(1):36-38. PubMed ID: 27684455
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab.
    Hauschild A, Eichstaedt J, Möbus L, Kähler K, Weichenthal M, Schwarz T, Weidinger S.
    Eur J Cancer; 2017 May 19; 77():84-87. PubMed ID: 28365530
    [No Abstract] [Full Text] [Related]

  • 15. Pembrolizumab for Treatment of Patients with Advanced or Unresectable Melanoma.
    Sullivan RJ, Flaherty KT.
    Clin Cancer Res; 2015 Jul 01; 21(13):2892-7. PubMed ID: 25931451
    [Abstract] [Full Text] [Related]

  • 16. Pembrolizumab for the treatment of melanoma.
    Kumar SS, McNeil CM.
    Expert Rev Clin Pharmacol; 2015 Jul 01; 8(5):515-27. PubMed ID: 26146011
    [Abstract] [Full Text] [Related]

  • 17. Cutaneous Metastatic Melanoma Resembling a Halo Nevus, in the Setting of PD-1 Inhibition.
    Harvey NT, Millward M, Macgregor K, Bucat RP, Wood BA.
    Am J Dermatopathol; 2016 Dec 01; 38(12):e159-e162. PubMed ID: 27870733
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Drug therapy of melanoma: anti-CTLA-4 and anti-PD-1 antibodies].
    Robert C, Mateus C.
    Bull Acad Natl Med; 2014 Feb 01; 198(2):297-308. PubMed ID: 26263705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.